Callan Family Office LLC Invests $1.76 Million in HCA Healthcare, Inc. $HCA

Key Points

• Callan Family Office LLC acquired 4,522 shares of HCA Healthcare during the second quarter, worth approximately $1.76 million. Institutional investors and hedge funds collectively own 62.73% of the company.
• HCA reported quarterly revenue of $20.23 billion, up 8.7% year over year, and earnings of $7.59 per share, slightly exceeding analyst expectations.
• The company declared a quarterly dividend of $0.78 per share, equivalent to an annualized $3.12 payout and a 0.7% yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $462.64.

Callan Family Office LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,522 shares of the company's stock, valued at approximately $1,763,000.

Other large investors also recently made changes to their positions in the company. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth $26,000. MidFirst Bank bought a new position in HCA Healthcare during the second quarter worth about $28,000. Clearstead Trust LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $29,000. Ares Financial Consulting LLC bought a new position in HCA Healthcare during the 4th quarter worth approximately $31,000. Finally, Cedar Mountain Advisors LLC bought a new stake in HCA Healthcare in the first quarter valued at approximately $33,000. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA stock opened at $429.08 on Monday. The business has a 50-day moving average of $397.16 and a 200-day moving average of $443.77. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The stock has a market capitalization of $92.90 billion, a P/E ratio of 14.36, a P/E/G ratio of 1.49 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion for the quarter, compared to analysts' expectations of $19.76 billion. During the same quarter in the previous year, the business posted $6.84 EPS. The business's quarterly revenue was up 8.7% compared to the same quarter last year. Equities analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's payout ratio is presently 10.45%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HCA. Stephens decreased their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating for the company in a report on Monday, April 27th. Deutsche Bank Aktiengesellschaft set a $476.00 target price on HCA Healthcare in a research note on Monday, July 27th. Barclays cut their price objective on HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating on the stock in a report on Monday, July 27th. Argus lowered their target price on HCA Healthcare from $560.00 to $500.00 and set a "buy" rating for the company in a research note on Monday, May 4th. Finally, Wall Street Zen cut shares of HCA Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, May 2nd. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source